These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27432475)

  • 1. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Gray JL; Gilbert SH; Coyne AG; McLean KJ; Davis HJ; Munro AW; Abell C
    ChemMedChem; 2016 Sep; 11(17):1924-35. PubMed ID: 27432475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Coyne AG; McLean KJ; James GG; Levy CW; Marino LB; de Carvalho LP; Chan DS; Hudson SA; Surade S; Leys D; Munro AW; Abell C
    J Med Chem; 2016 Apr; 59(7):3272-302. PubMed ID: 27002486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
    Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
    J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationships of
    Rajput S; McLean KJ; Poddar H; Selvam IR; Nagalingam G; Triccas JA; Levy CW; Munro AW; Hutton CA
    J Med Chem; 2019 Nov; 62(21):9792-9805. PubMed ID: 31618032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
    Belin P; Le Du MH; Fielding A; Lequin O; Jacquet M; Charbonnier JB; Lecoq A; Thai R; Courçon M; Masson C; Dugave C; Genet R; Pernodet JL; Gondry M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7426-31. PubMed ID: 19416919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products.
    Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E
    Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
    Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
    ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
    McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
    J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis.
    Davis HJ; Kavanagh ME; Balan T; Abell C; Coyne AG
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3735-40. PubMed ID: 27287372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
    El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
    Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from
    Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A
    J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.
    Fielding AJ; Dornevil K; Ma L; Davis I; Liu A
    J Am Chem Soc; 2017 Dec; 139(48):17484-17499. PubMed ID: 29090577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of
    Bajrai LH; Khateb AM; Alawi MM; Felemban HR; Sindi AA; Dwivedi VD; Azhar EI
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Tyrphostin Analogues to Study Inhibition of the Mycobacterium tuberculosis Pup Proteasome System*.
    Janssen GV; Zhang S; Merkx R; Schiesswohl C; Chatterjee C; Darwin KH; Geurink PP; van der Heden van Noort GJ; Ovaa H
    Chembiochem; 2021 Nov; 22(21):3082-3089. PubMed ID: 34387015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.
    Brunner K; Maric S; Reshma RS; Almqvist H; Seashore-Ludlow B; Gustavsson AL; Poyraz Ö; Yogeeswari P; Lundbäck T; Vallin M; Sriram D; Schnell R; Schneider G
    J Med Chem; 2016 Jul; 59(14):6848-59. PubMed ID: 27379713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel Antimycobacterials.
    Brengel C; Thomann A; Schifrin A; Allegretta G; Kamal AAM; Haupenthal J; Schnorr I; Cho SH; Franzblau SG; Empting M; Eberhard J; Hartmann RW
    ChemMedChem; 2017 Oct; 12(19):1616-1626. PubMed ID: 28815923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.
    McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW
    Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Alokam R; Jeankumar VU; Sridevi JP; Matikonda SS; Peddi S; Alvala M; Yogeeswari P; Sriram D
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):547-54. PubMed ID: 24090423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121.
    Hudson SA; McLean KJ; Surade S; Yang YQ; Leys D; Ciulli A; Munro AW; Abell C
    Angew Chem Int Ed Engl; 2012 Sep; 51(37):9311-6. PubMed ID: 22890978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.